Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response
Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response
Acute skin inflammation occurs following topical aminolevulinic acid-photodynamic therapy (ALA-PDT), but its nature and mediation are ill defined. As we observed an urticarial response, a potential role for histamine was explored. In 13 healthy volunteers, we assessed the time course and dose–response of the acute cutaneous response(s) to ALA-PDT, the impact of H1 antihistamine blockade, and measured dermal histamine release. An ALA dose series was iontophoresed into ventral forearm skin and exposed to red light. All participants exhibited an immediate urticarial response, both wheal and flare correlating with log ALA dose. Subsequently, a dose-related erythema developed at treatment sites by 3 hours and persisted at 24 hours. H1 blockade with oral cetirizine doubled the median minimal urticating dose of ALA and reduced the slope of dose–response for wheal and flare, whereas at the highest ALA dose, mean wheal and flare areas reduced by 68 and 60%, respectively. In contrast, cetirizine did not influence the 24 hour minimal phototoxic dose or erythema dose–response. Histamine release after ALA-PDT mirrored the urticarial response, levels peaking within 30 minutes and returning to baseline by 24 hours. Thus, two discrete acute inflammatory responses to topical ALA-PDT occur in human skin; histamine mediates the immediate response, but does not appear involved in the delayed phototoxicity.
2296-2301
Brooke, Rebecca C.C.
89d893f3-0924-49f2-8662-b225e27da6b3
Sinha, Animesh
90f776e5-1457-47f6-9be3-efed7875c0ef
Sidhu, K.
b3c38176-6aed-4d16-b9ae-c1dab03515d9
Watson, Rachel E.B.
685f568d-da1c-44ef-a2fa-9ddc1e9145d1
Church, Martin K.
dad189d5-866e-4ae1-b005-0d87f74282b8
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Clough, Geraldine F.
9f19639e-a929-4976-ac35-259f9011c494
Rhodes, Lesley E.
4ba4bef2-e70a-4350-b932-8ffd46699bf7
2006
Brooke, Rebecca C.C.
89d893f3-0924-49f2-8662-b225e27da6b3
Sinha, Animesh
90f776e5-1457-47f6-9be3-efed7875c0ef
Sidhu, K.
b3c38176-6aed-4d16-b9ae-c1dab03515d9
Watson, Rachel E.B.
685f568d-da1c-44ef-a2fa-9ddc1e9145d1
Church, Martin K.
dad189d5-866e-4ae1-b005-0d87f74282b8
Friedmann, Peter S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Clough, Geraldine F.
9f19639e-a929-4976-ac35-259f9011c494
Rhodes, Lesley E.
4ba4bef2-e70a-4350-b932-8ffd46699bf7
Brooke, Rebecca C.C., Sinha, Animesh, Sidhu, K., Watson, Rachel E.B., Church, Martin K., Friedmann, Peter S., Clough, Geraldine F. and Rhodes, Lesley E.
(2006)
Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response.
Journal of Investigative Dermatology, 126 (10), .
(doi:10.1038/sj.jid.5700449).
Abstract
Acute skin inflammation occurs following topical aminolevulinic acid-photodynamic therapy (ALA-PDT), but its nature and mediation are ill defined. As we observed an urticarial response, a potential role for histamine was explored. In 13 healthy volunteers, we assessed the time course and dose–response of the acute cutaneous response(s) to ALA-PDT, the impact of H1 antihistamine blockade, and measured dermal histamine release. An ALA dose series was iontophoresed into ventral forearm skin and exposed to red light. All participants exhibited an immediate urticarial response, both wheal and flare correlating with log ALA dose. Subsequently, a dose-related erythema developed at treatment sites by 3 hours and persisted at 24 hours. H1 blockade with oral cetirizine doubled the median minimal urticating dose of ALA and reduced the slope of dose–response for wheal and flare, whereas at the highest ALA dose, mean wheal and flare areas reduced by 68 and 60%, respectively. In contrast, cetirizine did not influence the 24 hour minimal phototoxic dose or erythema dose–response. Histamine release after ALA-PDT mirrored the urticarial response, levels peaking within 30 minutes and returning to baseline by 24 hours. Thus, two discrete acute inflammatory responses to topical ALA-PDT occur in human skin; histamine mediates the immediate response, but does not appear involved in the delayed phototoxicity.
This record has no associated files available for download.
More information
Published date: 2006
Identifiers
Local EPrints ID: 44264
URI: http://eprints.soton.ac.uk/id/eprint/44264
ISSN: 0022-202X
PURE UUID: 052cf8b5-67d5-4635-932a-f6e4018f64d0
Catalogue record
Date deposited: 21 Feb 2007
Last modified: 16 Mar 2024 02:54
Export record
Altmetrics
Contributors
Author:
Rebecca C.C. Brooke
Author:
Animesh Sinha
Author:
K. Sidhu
Author:
Rachel E.B. Watson
Author:
Martin K. Church
Author:
Peter S. Friedmann
Author:
Lesley E. Rhodes
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics